Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOPP.L Regulatory News (OPP)

  • There is currently no data for OPP

Assignment of loan

10 Apr 2008 16:30

Origo Sino-India PLC10 April 2008 10 April 2008 Origo Sino India assigns RIBEC loan Origo Sino-India plc ("Origo" or "the Company") (AIM: OSI), the investment andstrategic advisory company focused on the private equity markets of China andIndia, announces the assignment of a loan previously made by Origo to RoshiniInternational Bio-Energy Corporation ("RIBEC"). Further to Origo's announcement of 28 January 2008, the Company has assigned toOrigo Resource Partners Limited ("ORP") at cost US$1 million in a convertiblenote previously extended to RIBEC by Origo. ORP is the CISX and AIM listednatural resource fund to which the Company provides consultancy services. Anadditional sum of US$40,000 relating to interest receivable has also beenassigned. Origo had previously assigned a further US$1 million of the convertible loan toanother third party and Origo's remaining interest in RIBEC is now shares whichequate to an interest of approximately 17% in RIBEC's share capital on a fullydiluted basis. RIBEC is a fast growing, profitable company that produces non-edible, tree-bornebio energy feedstock and is based in Hyderabad, India. RIBEC's unaudited pre-taxprofits for the year ended 31 March 2007 were 165.7 million Rupees(approximately £2.1 million) and its unaudited net asset value at that date was43.9 million Rupees (approximately £0.6 million). The proceeds of the assignmentwill be used by Origo for general working capital purposes. ENDS Further information: Origo Resource Partners Limited +86 1390 124 6417 Chris Rynningchris@origoplc.com Nominated Adviser: +44 (0)20 7131 4000Smith & Williamson Corporate Finance LimitedAzhic Basirov Broker: +44 (0)20 3100 2223Liberum Capital LimitedSimon Atkinson Public Relations: +44 (0)20 7321 0000Aura FinancialMichael Oke/Andy Mills Notes to editors: Origo Sino-India Plc ("Origo"): • Origo is an established private equity investor and strategic consultancy business, which provides its shareholders with exposure to growth opportunities and private equity returns in China and India. • Origo's business model is to generate capital gains from private equity investment in growth companies from which it also generates fees for consultancy services related to further fundraisings, M&A and strategic development. • Origo is aligned with two major institutions which provide a source of high quality deal flow. In China, Origo works closely with China Equity, a leading private equity firm, whose chief executive is a member of Origo's board. In India, Origo has entered into a memorandum of understanding with SBI Capital Markets, one of the longest established companies in the Indian Capital Markets. A former chairman of the State Bank of India is also a member of the board of Origo. • On its admission to AIM in December 2006 Origo raised £12.8 million gross of new money via a placing of 25,673,238 Ordinary Shares at 50 pence per share. Each ordinary share carried a warrant exercisable at 55p. • Origo has a significant portfolio of investments in a range of industrial sectors, including mobile applications and content; natural resources; art and paper products; furniture; food and beverage; online gaming; anti-virus software; and bio energy. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th May 20227:00 amRNSCancellation - Origo Partners Plc
27th May 20226:00 pmRNSOrigo Partners
28th Apr 20227:30 amRNSSuspension – Origo Partners plc
26th Apr 20227:00 amRNSSuspension from Trading
7th Mar 20227:00 amRNSAsset Sale Update
2nd Feb 20227:00 amRNSReturn of Capital and Asset Sale
27th Jan 20223:16 pmRNSAsset Sale
24th Dec 202110:46 amRNSResult of AGM
6th Dec 20213:34 pmRNSNotice of AGM
3rd Dec 20217:00 amRNSInvestment Update
22nd Sep 20217:00 amRNSHalf-year Report
28th Jun 20217:00 amRNSAnnual Financial Report
4th Jun 20217:00 amRNSSale of Shares in Gobi Coal & Energy Ltd
14th May 202111:18 amRNSHolding(s) in Company
9th Mar 202112:20 pmRNSHolding(s) in Company
8th Mar 20217:00 amRNSStatement re share price movement
24th Feb 20214:27 pmRNSHolding(s) in Company
23rd Feb 20219:53 amRNSHolding(s) in Company
27th Jan 20218:38 amRNSUpdate re Website
22nd Jan 202110:03 amRNSUpdate re Remaining Assets
24th Dec 202011:20 amRNSResult of AGM
24th Dec 202010:14 amRNSHolding(s) in Company
24th Dec 20209:51 amRNSHolding(s) in Company
17th Dec 202012:38 pmRNSHolding(s) in Company
30th Nov 20204:30 pmRNSNotice of AGM
28th Sep 20207:00 amRNSHalf-year Report
23rd Sep 20207:09 amRNSPrice Monitoring Extension
23rd Sep 20207:02 amRNSSecond Price Monitoring Extn
22nd Sep 20202:06 pmRNSSecond Price Monitoring Extn
22nd Sep 20202:01 pmRNSPrice Monitoring Extension
30th Jun 20207:00 amRNSAnnual Financial Report
12th Jun 20207:00 amRNSInvestment update
20th May 202011:00 amRNSHolding(s) in Company
7th May 20207:00 amRNSUpdate RE: Liquidation Plans
29th Apr 20202:06 pmRNSSecond Price Monitoring Extn
29th Apr 20202:02 pmRNSPrice Monitoring Extension
17th Mar 202012:12 pmRNSChange of Registered Office & Update on Website
12th Mar 20203:32 pmRNSWebsite
4th Feb 20207:00 amRNSInvestment Update
24th Dec 20197:00 amRNSInvestors update
11th Nov 201911:33 amRNSHolding(s) in Company
30th Oct 20194:16 pmRNSResult of AGM
23rd Oct 201910:41 amRNSHolding(s) in Company
23rd Oct 201910:39 amRNSHolding(s) in Company
4th Oct 20194:23 pmRNSNotice of AGM
27th Sep 20194:25 pmRNSReplacement Capital Distribution
27th Sep 201911:05 amRNSReplacement Interim Unaudited Financial Statements
27th Sep 20197:05 amRNSCapital Distribution
27th Sep 20197:00 amRNSInterim Unaudited Financial Statements
28th Jun 20194:15 pmRNSPosting of Annual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.